• Biosimilars
  • Drug Development/R&D
  • All Topics
OHE OHE
Newsletter SignupSubscribe

News & Insights
  • News
  • Events
  • Insights
  • Bulletin
  • News
  • Events
  • Insights
  • Bulletin

News & Insights

  • News
  • Events
  • Insights
  • Bulletin
Newsletter SignupSubscribe
  • News
  • Events
  • Insights
  • Bulletin

Close
OHE OHE
  • Research & Publications
  • News & Insights
  • Education
  • Innovation Policy Prize
  • Events
  • About Us
  • OHE Experts
  • Contact Us
Newsletter SignupSubscribe

Research & Publications

All Publications

Filter by:
  • Antimicrobial Resistance (AMR)
  • Biosimilars
  • Cell and Gene Therapies
  • Chronic Diseases
  • Combination Therapies
  • COVID-19 Research
  • Digital Health
  • Drug Development/R&D
  • Emerging Markets
  • EQ-5D and PROMs
  • Health Care Systems
  • Health Data and Statistics
  • Health Technology Assessment
  • Precision Medicine
  • Real World Evidence
  • Use of Medicines
  • Value-Based Pricing
  • Vaccine Research
  • Economics of Innovation
  • Measuring and Valuing Outcomes
  • Policy, Organisation and Incentives in Health Systems
  • Value, Affordability and Decision Making

News & Insights

  • News
  • Events
  • Insights
  • Bulletin

Education

  • Education Hub
  • OHE Graduate School
  • EVIA Programme

Innovation Policy Prize

  • The Prize Fund
  • 2022 Prize Fund

Latest Research & Publications

Proposal for a General Outcome-based Value Attribution Framework for Combination Therapies

CombTher_Adobe_photoguns_portrait
Read more
© photoguns
  • Digital Health

Navigating the Landscape of Digital Health – United Kingdom

Healthcare_Adobe_elenabsl
Read more

2021 OHE Annual Report to the Charity Commission

charityreport_lina-trochez-unsplash_landscape
Read more
© Lina Trochez/Unsplash

Supporting the Era of Green Pharmaceuticals in the UK

Sustainability_AdobeStock_270582392_landscape
Read more

Quality of life and wellbeing in individuals with experience of fertility problems and assisted reproductive techniques

Quality of life assisted reproduction Cover
Read more
  • Cell and Gene Therapies
  • Value, Affordability, and…

Health Technology Assessment of Gene Therapies: Are Our Methods Fit for Purpose?

gene_therapies_national-cancer-institute-unsplash_landscape
Read more
© NCI/Unsplash
  • Drug Development/R&D
  • Economics of Innovation
  • Health Policy and Regulation

Limitations of CBO’s Simulation Model of New Drug Development as a Tool for Policymakers

CBO-US_mayer-tawfik-K4Ckc0AxgDI-unsplash_landscape
Read more
© Mayer Tawfik/Unsplash
  • Measuring and Valuing Outcomes

When Generic Measures Fail to Reflect What Matters to Patients: Three Case Studies

PROMS_unsplash_National Cancer Institute_landscape
Read more
© NCI/Unsplash
Close
OHE
  • All Publications

    Filter by:
    • Antimicrobial Resistance (AMR)
    • Biosimilars
    • Cell and Gene Therapies
    • Chronic Diseases
    • Combination Therapies
    • COVID-19 Research
    • Digital Health
    • Drug Development/R&D
    • Emerging Markets
    • EQ-5D and PROMs
    • Health Care Systems
    • Health Data and Statistics
    • Health Technology Assessment
    • Precision Medicine
    • Real World Evidence
    • Use of Medicines
    • Value-Based Pricing
    • Vaccine Research
    • Economics of Innovation
    • Measuring and Valuing Outcomes
    • Policy, Organisation and Incentives in Health Systems
    • Value, Affordability and Decision Making
    • News
    • Events
    • Insights
    • Bulletin
    • Education Hub
    • OHE Graduate School
    • EVIA Programme
    • The Prize Fund
    • 2022 Prize Fund
  • Events
  • About Us
  • OHE Experts
  • Contact Us
Newsletter SignupSubscribe
Back
  • Insight
11 min read 11th January 2021

OHE at HESG Winter 2021

Members from the team at OHE attended the Health Economists’ Study Group (HESG) Winter 2021 Meeting, hosted online by the Centre for Health Economics in London, LSHTM, from 6th-8th January 2021. The Health Economists’ Study Group Winter 2021 Meeting was…

Share:
  •  Twitter
  •  LinkedIn
  •  Facebook
  • has-icon Email

Members from the team at OHE attended the Health Economists’ Study Group (HESG) Winter 2021 Meeting, hosted online by the Centre for Health Economics in London, LSHTM, from 6th-8th January 2021.

The Health Economists’ Study Group Winter 2021 Meeting was hosted online by the Centre for Health Economics in London, LSHTM, from 6th-8th January 2021.

This year the OHE discussed and chaired lively and thought-provoking discussions on various topics as outlined below:

On Wednesday 6th January, Chris Sampson lead a discussion on ‘The FLIGHT trial. Whose decision matters and what matters most? Comparing QALYs, capabilities and platelets’ by Dr Katie Breheny (University of Bristol) which was chaired by Prof Katherine Payne (University of Manchester).

Chris explained the paper was “on the challenge of economic evaluation when outcomes diverge: what if one outcome favours the intervention while another favours the control?” His presentation focused on “the theoretically challenging aspects of the paper with regard to quality-adjusted life years, capabilities, and clinical indicators.” The session included a lively conversation about best practice in within-trial economic evaluations and how researchers should identify the most important outcomes for patients, the NHS, and other stakeholders.

On the same day, Mireia Jofre-Bonet chaired the session ‘Validating the use of estimated intervention effects on psychological variables to predict BMI and the cost-effectiveness of a behavioural weight management intervention’ by Sarah Bates (University of Sheffield) et al.  The discussion was by lead by Dr Ka Keat (King’s College London).

Mireia described the discussion as “very thorough and constructive.” Participants, author and discussant reflected on how the effect of interventions on conditions such as obesity depend on habit changing. Thus, understanding what affects the habits (mediator) in the medium and long run, and how these affect the final outcome (weight loss) will help design successful interventions. The participants also discussed the importance of understanding the quality of life of those affected by obesity.

On Thursday 7th January, Bernarda Zamora lead the discussion on ‘Task shifting inguinal hernia repair between surgeons and non-surgeon physicians: Workforce-Modelling’ by Mark Monahan (University of Birmingham) which was chaired by Prof Linda Davies (University of Manchester)

Bernarda’s discussion focused on strengthening the policy implications of task-shifting hernia surgery from surgeons to non-surgeon physicians. She noted that the paper would benefit from widening these implications by using the qualitative interviews. Other participants also highlighted the rich data from site visits and how these could complement the interpretation of the model results.

On Friday 8th January, Mireia Jofre-Bonet discussed the paper ‘Primary Care Mortality and General Practice Funding: A National Longitudinal Study 2013-2016’ by Veline L’Esperance’ by Mark Ashworth, Peter Schofield, and Hugh Gravelle. (Kings College London) which was chaired by Dr Jonathan Stokes (University of Manchester).

Mireia explained: “This study analyses the association between health care spending at the primary care level and mortality exploiting panel data that combines seven different datasets: the Primary Care Mortality dataset, the General and Personal Medical Services, the General Practice Patient Survey, the NHS payments to General Practices, the Quality and Outcome Framework data, the Index of Multiple Deprivation (IMD), and the census (to obtain ethnicity proportions by Lower Level of Super Output Areas (LLSOA).” The authors found that higher total practice funding was associated with increased mortality, which – without correcting for the reverse causality of funding – was expected. The discussant praised the magnitude of the work so far and provided constructive feedback. The presenting author, Veline L’Esperance, clarified that the authors are working on removing the circularity from the estimates and obtain the net effect of total funding on mortality. The general discussion involving chair, discussant, authors and participants was productive and helpful for the authors.

The Office of Health Economics is proud to announce that we will be hosting HESG in Summer 2025.

  • Research
  • Measuring and Valuing Outcomes
  • Presentations

Related Insights

HealthData&Stats_AdobeStock_168196575_landscape
  • Insight
  • August 2022

Improving the Measurement of Valued Output in Primary Care in England

Read more
Good and Broken Light Bulb
  • Insight
  • July 2022

Reforming Primary Health Care in Middle-Income Countries: The Good, the Bad, and the Ugly

Read more
  • Insight
  • March 2021

Efficiency Measurement in Primary Care: Time to Overcome the Challenges and Achieve Some Gains

Read more
  • Insight
  • January 2021

Bridging the Gap: Pathways for Regulatory and Health Technology Assessment of Histology Independent Cancer Treatments

Read more
footer_ohe_logo

Leading intellectual authority on global health economics

Sign Up for the OHE News Bulletin

Newsletter SignupStart Sign Up

Research & Publications

News & Insights

Innovation Policy Prize

Education

Events

About Us

OHE Experts

Contact Us

Sign Up for the OHE News Bulletin

Newsletter SignupStart Sign Up

The Office of Health Economics (OHE) is a company limited by guarantee registered in England and Wales (registered number 09848965) and its registered office is at 2nd Floor Goldings House, Hay’s Galleria, 2 Hay’s Lane, London, SE1 2HB.

Terms & Conditions

Privacy Policy

Cookies Policy

© 2023 Website Design

An error has occurred, please try again later.An error has occurred, please try again later.

We are using cookies to give you the best experience on our website.

You can find out more about which cookies we are using or switch them off in settings.

 Twitter
 Facebook
 LinkedIn
 Copy
 Email
Powered by  GDPR Cookie Compliance
Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.

Strictly Necessary Cookies

Strictly Necessary Cookie should be enabled at all times so that we can save your preferences for cookie settings.

If you disable this cookie, we will not be able to save your preferences. This means that every time you visit this website you will need to enable or disable cookies again.

3rd Party Cookies

This website uses Google Analytics to collect anonymous information such as the number of visitors to the site, and the most popular pages.

Keeping this cookie enabled helps us to improve our website.

Please enable Strictly Necessary Cookies first so that we can save your preferences!